G. Raghu (Seattle, United States of America), S. Tomassetti (Forli, Italy)
Late Breaking Abstract: Pulmonary hypertension (PH) in patients with idiopathic pulmonary fibrosis (IPF) in early course of disease – A prospective evaluation with right heart catheterization (RHC) in the ARTEMIS-IPF study
G. Raghu, J. Behr, K. Brown, J. Egan, K. Flaherty, S. Kawut, F. Martinez, A. Wells, D. Zisman, T. DeVries, B. Appleton, L. Dean (Seattle, Denver, Ann Arbor, Philadelphia, Santa Barbara, United States Of America; Munich, Germany; Dublin, Ireland; London, United Kingdom)
|  |
Late Breaking Abstract: Non-steroid agents for idiopathic pulmonary fibrosis: A systematic review
P. Spagnolo, C. Del Giovane, F. Luppi, S. Cerri, S. Balduzzi, E. H. Walters, R. D‘Amico, L. Richeldi (Modena, Italy; Hobart, Australia)
|  |
Late Breaking Abstract: Comparison between referral diagnosis of patients requiring transplantation due to interstitial lung diseases and pathological diagnosis of native lungs
T. Laurent, M. Rabeyrin, A. Jankowski, M. Jeanmart, G. Ferretti, S. Lantuejoul, C. Pison (Grenoble, France)
| |
Clinical profile of sarcoidosis in Estonia
H. Lill, K. Kliiman, K. Jaama, H. Leesik (Estonia)
| |
The importance of defined comorbities in sarcoidosis
J. Videnovic-Ivanov, V. Mihailovic-Vucinic, S. Filipovic, V. Zugic, J. Maric-Zivkovic (Belgrade, Republic Of Serbia)
| |
Interstitial lung diseases: Data analysis from a Portuguese respiratory reference hospital
S. Campainha, C. Nogueira, C. Brito, S. Torres, A. Couceiro, F. Costa, S. Neves (Vila Nova de Gaia, Portugal)
| |
Age at diagnosis and degree of pulmonary function tests disturbances in hypersensitivity pneumonitis (HP) patients
U. Nowicka, E. Wiatr, J. Grudny, I. Bestry, P. Boros, B. Roszkowska (Warsaw, Poland)
| |
Bronchial hyperresponse in hypersensitivity pneumonitis
A. Villar-Gómez, X. Muñoz, S. Sanchez-Vidaurre, M. J. Cruz, M. D. Untoria, F. Morell (Barcelona, Spain)
| |
Risk factors for pulmonary hypertension and associations with lung function in connective tissue diseases
E. Serasli, M. Antoniadou, C. Karvounis, S. Papoti, V. Michailidis, V. Tsara (Thessaloniki, Greece)
| |
Sarcoidosis presenting as Lofgren‘s syndrome
M. Saleem, M. McDonnell, A. Talbot, R. Rutherford, A. O‘Regan, J. J. Gilmartin (Galway, Ireland)
| |
Clinical features of cryptogenic organizing pneumonia in a Chilean population
M. Rodriguez Vial, J. C. Rodriguez Duque, A. Undurraga (Santiago, Chile)
| |
Rituximab treatment of a case of anti-syntetase syndrome with severe interstitial lung disease and acute respiratory failure
M. C. Zappa, T. Trequattrini, F. Mattioli, R. Rivitti, S. Cardo, A. Marcoccia (Rome, Italy)
| |
Correction of endothelial dysfunction in patients with COPD, IPF
N. V. Yahorava, I. S. Karpova, H. L. Hurevich (Minsk, Belarus)
| |
Antigen presenting cells of lower airways in interstitial lung diseases (ILD). Do alveolar lymphocytes possess the ability to present antigens?
P. Kopinski, J. Szczeklik, J. Chorostowska-Wynimko, B. Balicka-Slusarczyk, A. Szpechcinski, G. Przybylski, A. Jarzemska, E. Polgesek (Bygoszcz-Torun, Krakow, Warszawa, Bydgoszcz-Torun, Poland)
| |
Nutritional evaluation and physical activity in scleroderma patients
M. Messina, N. Scichilone, S. Battaglia, M. Bellia, M. Midiri, A. Paternò, A. Giardina, G. Triolo, V. Bellia (Italy)
| |
The effectiveness of plasmaferesis in patients with relapsing and progressing course of pulmonary sarcoidosis (5 years follow-up)
O. Baranova, V. Voinov, O. Baclanova, E. Surkova (St. Petersberg, Russian Federation)
| |
Considerations of a warm autopsy program for patients with idiopathic pulmonary fibrosis
K. Lindell, L. Hoffman, T. Richards, K. Gibson, M. Bisceglia, R. Dhir, L. Nichols, S. Yousem, N. Kaminski (Pittsburgh, United States Of America)
| |
Profile of interstitial lung disease at a district general hospital
P. Whittemore, G. Ng Man Kwong, C. Houghton (Manchester, United Kingdom)
| |
Can soluble CD-163 be related to disease activity in pulmonary sarcoidosis?
N. Milman, C. B. Svendsen, H. J. Moller (Copenhagen, Aarhus, Denmark)
| |
Acute exacerbation of interstitial lung diseases as a cause of respiratory failure. Our 3-years experience
L. Stehlík, M. Vašáková, J. Chlumský (Prague, Czech Republic)
| |